- Corporate Officers - O
- Orbimed Israel Gp Ii, L.p.
Insider Trading History of Orbimed Israel Gp Ii, L.p.
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Orbimed Israel Gp Ii, L.p. since 2018.
This trader's CIK number is 1682090.
At the time of last reporting, Orbimed Israel Gp Ii, L.p. was the Officer of Upstream Bio, Inc.. (stock ticker symbol UPB).
Also see all insider trading activities at Upstream Bio, Inc..
Note that in the past
OrbiMed Israel GP II, L.P. also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Steadymed Ltd. (STDY) by Orbimed Israel Gp Ii, L.p.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | STDY | 0 | $0 | 4,246,196 | $18,938,034 | 0 | $0 |
Yearly summary of insider trading at 89bio, Inc. (ETNB) by Orbimed Israel Gp Ii, L.p.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2022 | ETNB | 0 | $0 | 70,573 | $592,383 | 0 | $0 |
| 2020 | ETNB | 0 | $0 | 275,000 | $7,700,000 | 0 | $0 |
| 2019 | ETNB | 837,500 | $13,400,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Upstream Bio, Inc. (UPB) by Orbimed Israel Gp Ii, L.p.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2024 | UPB | 825,000 | $14,025,000 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Logicbio Therapeutics, Inc. (LOGC) by Orbimed Israel Gp Ii, L.p.
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2018 | LOGC | 1,190,000 | $11,900,000 | 0 | $0 | 0 | $0 |
Insider trading activities at 4 companies by Orbimed Israel Gp Ii, L.p.:
1. Steadymed Ltd. (STDY)
2. 89bio, Inc. (ETNB)
3. Upstream Bio, Inc. (UPB)
4. Logicbio Therapeutics, Inc. (LOGC)
Table 1. Insider trading of Steadymed Ltd. (STDY) by Orbimed Israel Gp Ii, L.p.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-08-30 | STDY | Sale | 4,246,196 | 4.46 | 18,938,034 |
Table 2. Insider trading of 89bio, Inc. (ETNB) by Orbimed Israel Gp Ii, L.p.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2022-01-26 | ETNB | Sale | 21,482 | 8.38 | 180,019 |
| 2022-01-25 | ETNB | Sale | 49,091 | 8.40 | 412,364 |
| 2020-09-21 | ETNB | Sale | 275,000 | 28.00 | 7,700,000 |
| 2019-11-11 | ETNB | Buy | 837,500 | 16.00 | 13,400,000 |
Table 3. Insider trading of Upstream Bio, Inc. (UPB) by Orbimed Israel Gp Ii, L.p.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2024-10-15 | UPB | Buy | 825,000 | 17.00 | 14,025,000 |
Table 4. Insider trading of Logicbio Therapeutics, Inc. (LOGC) by Orbimed Israel Gp Ii, L.p.
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2018-10-23 | LOGC | Buy | 1,190,000 | 10.00 | 11,900,000 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Orbimed Israel Gp Ii, L.p.
(Officer of Upstream Bio, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.